ERBB2 and breast carcinoma: Interestingly, simultaneous supplementation of oleate and palmitate completely abrogates the observed toxicity of palmitate supplementation in the HER2/neu-positive SKBR3 breast cancer cells, even though the total amount of supplemented FAs exceeds that of palmitate alone.